Gelesis Holdings Revenue 2021-2022 | GLS
Gelesis Holdings revenue from 2021 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Gelesis Holdings Annual Revenue
(Millions of US $) |
| 2021 |
$ |
| 2020 |
$ |
| 2019 |
$ |
Gelesis Holdings Quarterly Revenue
(Millions of US $) |
| 2022-03-31 |
$8 |
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
$3 |
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.111B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
